Anaptysbio ANAB
NASDAQ ANAB
$50.37 -0.43 (-0.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) Non-Current Debt (2016 - 2018)

Updated

Anaptysbio's Non-Current Debt was $10 million in FY2016.

Analysis

Anaptysbio (ANAB) Non-Current Debt (2016 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Anaptysbio 1.47 Bn 362.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 625,000.00
Sep 30, 2018 2.41 Mn
Jun 30, 2018 4.12 Mn
Mar 31, 2018 5.83 Mn
Dec 31, 2017 7.55 Mn
Sep 30, 2017 9.27 Mn
Jun 30, 2017 10.99 Mn
Mar 31, 2017 12.71 Mn
Dec 31, 2016 13.81 Mn
API Access

Anaptysbio Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ANAB&period=max&api_key=YOUR_API_KEY